Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Kans op val verdubbeld na een lichte beroerte of TIA
nov 2023 | Neuro-vasculair